Other studies have genetically engineered MSCs to overexpress TNF-related apoptosis-inducing ligand (TRAIL) or bone morphogenetic protein 4 (BMP4), showing strong anti-tumor activity in brain cancer 6,7. Here, TNFSF10 is linked to neoplasm.